The effect of etanercept and methylprednisolone on functional recovery of the facial nerve after crush injury

Otology and Neurotology

Volumn 35, Issue 7, 2014, Pages 1277-1283

  Topdag, Murat ^a   Iseri, Mete ^a   Topdag, Deniz Ozlem ^a   Kokturk, Sibel ^b   Ozturk, Murat ^a   Iseri, Pervin ^a  

^a KOCAELI UNIVERSITY   (Turkey)

^b ORDU UNIVERSITY   (Turkey)

Author keywords

Antagonist; Crush injury; Etanercept; Facial nerve; Methylprednisolone; Tumor necrosis factor

Indexed keywords

EID: 85038934825     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0000000000000359     Document Type: Article

References (24)

1. Yeh C, Bowers D, Hadlock TA. Effect of FK506 on functional recovery after facial nerve injury in the rat. Arch Facial Plast Surg 2007;9:333-9.
2. Shamash S, Reichert F, Rotshenker S. The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J Neurosci 2002;22:3052-60.
3. Shubayev VI, Myers RR. Upregulation and interaction of TNFalpha and gelatinases A and B in painful peripheral nerve injury. Brain Res 2000;855:83-9.
4. Wagner R, Myers RR. Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience 1996;73:625-9.
5. Schafers M, Geis C, Brors D, Yaksh TL, Sommer C. Anterograde transport of tumor necrosis factor- alpha in the intact and injured rat sciatic nerve. J Neurosci 2002;22:536-45.
6. Ito M, Ohbayashi M, Furukawa M, Okoyama S. Neuroprotective effects of TJ-23 (Tokishakuyakusan) on adult rat motoneurons following peripheral facial nerve axotomy. Otolaryngol Head Neck Surg 2007;136:225-30.
7. Reinecke K, Lucius R, Reinecke A, Rickert U, Herdegen T, Unger T. Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-kappaB. FASEB J 2003;17:2094-6.
8. Hindley S, Juurlink BH, Gysbers JW, Middlemiss PJ, Herman MA, Rathbone MP. Nitric oxide donors enhance neurotrophin-induced neurite outgrowth through a cGMP-dependent mechanism. J Neurosci Res 1997;47:427-39.
9. Gonzalez-Hernandez T, Rustioni A. Nitric oxide synthase and growth-associated protein are coexpressed in primary sensory neurons after peripheral injury. J Comp Neurol 1999;404:64-74.
10. Kokturk S, Ceylan S, Etus V, Yasa N, Ceylan S. Morinda citrifolia L. (noni) and memantine attenuate periventricular tissue injury of the fourth ventricle in hydrocephalic rabbits. Neural Regen Res 2013;8:773-82.
11. Skripuletz T, Lindner M, Kotsiari A, et al. Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am J Pathol 2008;172:1053-61.
12. Tyagi A, Singh RP, Ramasamy K, et al. Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3. Cancer Prev Res (Phila) 2009;2:74-83.
13. Lisa SZ, Cameron JK, Amit M, Deirdre PM, Anna MH, Sydney ME. Hypoxia and VEGF mRNA Expression in Human Tumors. Neoplasia 2001;3:500-8.
14. Hetzler LE, Sharma N, Tanzer L, et al. Accelerating functional recovery after rat facial nerve injury: Effects of gonadal steroids and electrical stimulation. Otolaryngol Head Neck Surg 2008;139:66-7.
15. Genovese T, Mazzon E, Crisafulli C, et al. Immunomodulatory effects of etanercept in an experimental model of spinal cord injury. J Pharmacol Exp Ther 2006;316:1006-16.
16. Campbell SJ, Jiang Y, Davis AE, et al. Immunomodulatory effects of etanercept in a model of brain injury act through attenuation of the acute-phase response. J Neurochem 2007;103:2245-55.
17. Sommer C, Schafers M, Marziniak M, Toyka KV. Etanercept reduces hyperalgesia in experimental painful neuropathy. J Peripher Nerv Syst 2001;6:67-72.
18. Schafers M, Svensson CI, Sommer C, Sorkin LS. Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci 2003;23:2517-21.
19. Zanella JM, Burright EN, Hildebrand K, et al. Effect of etanercept, a tumor necrosis factor-alpha inhibitor, on neuropathic pain in the rat chronic constriction injury model. Spine 2008;33:227-34.
20. Kato K, Kikuchi S, Shubayev VI, Myers RR. Distribution and tumor necrosis factor-alpha isoform binding specificity of locally administered etanercept into injured and uninjured rat sciatic nerve. Neuroscience 2009;160:492-500.
21. Caminero A, Comabella M, Montalban X. Tumor necrosis factor alpha (TNF-alpha), anti-TNF-alpha and demyelination revisited: an ongoing story. J Neuroimmunol 2011;234:1-6.
22. Zalevsky J, Secher T, Ezhevsky SA, et al. Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection. J Immunol 2007;179: 1872-83.
23. Kinshi K, Huaqing L, Shin-ichi K, Robert RM, Veronica IS. Immediate anti-tumor necrosis factor-> (etanercept) therapy enhances axonal regeneration after sciatic nerve crush. Journal of Neuroscience Research 2010;88:360-8.
24. Hayashi S, Taira A, Inoue G, et al. TNF-alpha in nucleus pulposus induces sensory nerve growth: a study of the mechanism of discogenic low back pain using TNF-alpha-deficient mice. Spine 2008;33:1542-6.